Clinical Trial Update: Docetaxel, Cisplatin, and Amifostine in Treating Patients With Advanced Non-small Cell Lung Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating the combination of docetaxel, cisplatin, and amifostine in patients with advanced non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• ETHYOL (Amifostine)
• Platinol (cisplatin)
• Taxotere (docetaxel)

Snippet

Sponsor: University of Wisconsin, Madison | Conditions: Drug/Agent Toxicity by Tissue/Organ, Lung Cancer | Phase 1, Phase 2 | Status: UNKNOWN